Thus, the improvements in glucose indices [5, 54, 56–58], lipids [57, 58], inflammation [67], and anthropometrics [5, 54, 56], and subsequently NAFLD, may be attributed to increased nesfatin levels by NC supplementation. The gene discussed is NUCB2; the disease is metabolic dysfunction-associated steatotic liver disease.